“A Comprehensive Guide to Toxicology in Preclinical Drug Development” serves as an invaluable resource for toxicologists working in the pharmaceutical industry, regulatory bodies, and contract resource organizations.

This authoritative guide offers a thorough understanding of the drug development process, emphasizing practical insights through real-life case studies and examples.

It comprehensively covers the complex and interconnected activities of preclinical toxicology in both small molecules and biologics.

Topics include discovery toxicology, adherence to international safety evaluation guidelines, various toxicology models, and the development of drugs such as vaccines, oncology drugs, monoclonal antibodies, and more.

Additionally, it addresses essential aspects like study development, personnel, the role of imaging in preclinical evaluation, and materials supporting IND applications.

With contributions from world-renowned experts, this reference incorporates the latest research in preclinical drug testing, making it a comprehensive and actionable guide for all facets of preclinical drug development and testing.

A Comprehensive Guide to Toxicology in Preclinical Drug Development (Original PDF from Publisher)

1.2.Key Features

The key features of “A Comprehensive Guide to Toxicology in Preclinical Drug Development” include:

1. Expert Contributors: The book features chapters written by world-renowned experts in the field of toxicology, providing authoritative and up-to-date information.
2. Comprehensive Coverage: It covers all aspects of preclinical drug testing, making it a single-source reference for toxicologists and professionals involved in drug development.
3. Practical Insights: Incorporating real-life case studies and examples, the book offers practical scenarios and experiences from preclinical toxicology, enhancing its relevance and applicability.
4. International Guidelines: It discusses adherence to international guidelines for safety evaluation, ensuring that readers are well-versed in the regulatory requirements of drug development.
5. Inclusion of Small Molecules and Biologics: The book addresses preclinical toxicology for both small molecules and biologics, making it versatile and applicable to a wide range of drug development scenarios.
6. Diverse Drug Development Topics: Chapters cover various drug development areas, including vaccines, oncology drugs, monoclonal antibodies, and more, catering to different fields within the pharmaceutical industry.
7. Imaging in Preclinical Evaluation: The book highlights the role of imaging techniques in preclinical evaluation, providing insights into advanced assessment methods.
8. Support for IND Applications: It offers guidance on preparing supporting materials for Investigational New Drug (IND) applications, assisting professionals in navigating regulatory processes.

A Comprehensive Guide to Toxicology in Preclinical Drug Development

Summary

“A Comprehensive Guide to Toxicology in Preclinical Drug Development” is an essential resource for professionals in the pharmaceutical industry, regulatory bodies, and contract resource organizations. This comprehensive guide offers a thorough understanding of the complex and interconnected processes involved in preclinical drug testing for both small molecules and biologics.

With contributions from world-renowned experts, the book covers a wide range of topics, including adherence to international safety evaluation guidelines, practical insights through real-life case studies, the role of imaging in preclinical evaluation, and support for Investigational New Drug (IND) applications.

By incorporating the latest research and practical scenarios, this reference provides a complete and actionable guide for all aspects of preclinical drug development and testing, making it an invaluable tool for professionals in the field.